Lineage Cell Therapeutics
LCTX
#7577
Rank
S$0.50 B
Marketcap
S$2.19
Share price
-1.74%
Change (1 day)
172.30%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2025 (TTM): -S$26.85 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are S$10.81 Million. In 2024 the company made an earning of -S$27.85 Million, an increase over its 2023 earnings that were of -S$32.07 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$26.85 Million-3.6%
2024 -S$27.85 Million-13.16%
2023 -S$32.07 Million9.83%
2022 -S$29.2 Million-54.24%
2021 -S$63.81 Million86.07%
2020 -S$34.3 Million-31.97%
2019 -S$50.41 Million-5.42%
2018 -S$53.3 Million1.1%
2017 -S$52.72 Million-31.06%
2016 -S$76.46 Million-10.38%
2015 -S$85.32 Million29.69%
2014 -S$65.79 Million31.68%
2013 -S$49.97 Million
2011 -S$24.25 Million89.78%
2010 -S$12.78 Million206.06%
2009 -S$4.18 Million-0.58%
2008 -S$4.2 Million164.89%
2007 -S$1.59 Million-30.22%
2006 -S$2.28 Million
2002 -S$2.64 Million-41.04%
2001 -S$4.48 Million-32.04%
2000 -S$6.59 Million-11.85%
1999 -S$7.47 Million
1997 -S$4.8 Million12.12%
1996 -S$4.28 Million106.25%
1995 -S$2.08 Million-11.11%
1994 -S$2.34 Million50%
1993 -S$1.56 Million20%
1992 -S$1.3 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-S$0.2 Billion 627.71%๐Ÿ‡บ๐Ÿ‡ธ USA